AstraZeneca gets rights, options to basket of next-gen immuno-oncology therapies from Innate

AstraZeneca gets rights, options to basket of next-gen immuno-oncology therapies from Innate

Submitted by admin on October 23, 2018 - 11:02pm
Source: 
BioCentury
News Tags: 
AstraZeneca
Innate Pharma
oncology
Headline: 
AstraZeneca gets rights, options to basket of next-gen immuno-oncology therapies from Innate
snippet: 

AstraZeneca plc (LSE:AZN; NYSE:AZN) expanded its next generation immuno-oncology pipeline on Tuesday, gaining rights and options to a basket of therapies from Innate Pharma S.A. (Euronext:IPH). 

Do Not Allow Advertisers to Use My Personal information